DIA Board of Directors to Recognize Medidata's Vice President of Global
Regulatory Affairs and Quality Assurance at Annual Meeting
NEW YORK, June 11 /CNW/ - Medidata Solutions, a global leader in
electronic data capture (EDC), management and reporting solutions, today
announced that Vice President of Global Regulatory Affairs and Quality
Assurance Earl Hulihan has been selected to receive the Drug Information
Association's (DIA) Founders Service Award. This award recognizes individuals
who have advanced the mission, vision and values of DIA and fostered the
growth and development of the organization through their sustained dedication,
time and effort.
DIA's highest honor for volunteerism, the Founders Service Award honors
Hulihan's lifelong contributions to medicine, regulatory science and people
around the world throughout his distinguished career. Hulihan has helped the
industry make significant strides in quality assurance, regulatory compliance,
drug development and clinical research since the early 1970s. As the current
Vice President of Global Regulatory Affairs and Quality Assurance at Medidata
Solutions, Hulihan is responsible for maintaining the highest standards for
all Medidata products and services, and ensuring compliance with the US and
international clinical and quality regulations.
Outside of the professional environment, Hulihan has provided advice and
training to regulatory agency personnel within the U.S. FDA, European and
Asian communities and has more than 15 years of experience in clinical
medicine as a research specialist, teaching specialist, clinical physiologist
and clinical investigator. Hulihan has been involved with DIA for over 30
years and is a frequent contributor to seminars, training and events and
serves as global chair of the Validation SIAC/Community and vice-chair of the
DIA Advisory Council for North America. He has been very active in the most
recent launch of DIA initiatives within the India and China regions.
"DIA has always been one of the most influential associations and driving
forces in the industry, and I am honored to have been able to contribute to
the organization over the years," said Hulihan. "Medidata Solutions
consistently maintains a strong presence at DIA conferences and events, and I
look forward to continuing to drive critical discussions and foster commitment
to the DIA community."
Prior to joining Medidata, Hulihan served as senior vice president of
regulatory consulting services at META Solutions Inc. and vice president of
quality systems at EduQuest where he provided regulatory consulting, auditing
and training services to the global pharmaceutical, biologics and medical
device industries. Hulihan has held a variety of other senior management
positions in the global pharmaceutical environment serving both pharmaceutical
companies and CROs, and has been involved in research across the globe.
"Earl has shown an unmatched dedication to advancing the life sciences
industry through his commitment to the DIA community throughout his career,"
said Tarek Sherif, CEO of Medidata Solutions. "As one of the most sought after
thought-leaders within Medidata and the industry at large, Earl continues to
make vital contributions to his peers and colleagues that have helped drive
significant developments and shape the future of the clinical world."
The DIA Founders Service Award will be presented publicly during the DIA
Annual Meeting at the Georgia World Congress Center (GWCC) in Atlanta, Georgia
at 8:30 a.m. on June 18, 2007.
About Medidata Solutions Worldwide
Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit www.mdsol.com.
For further information:
For further information: Lois Paul & Partners Susan Lombardo,